Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
33.96
-0.18 (-0.53%)
Aug 21, 2026, 3:59 PM HKT

HKG:1501 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
218.79191.91156.46131.71142.96
Depreciation & Amortization
102.4578.5446.6336.4129.69
Other Amortization
1.781.330.920.670.52
Loss (Gain) From Sale of Assets
-0.480.020.620.240.11
Asset Writedown & Restructuring Costs
0.210.62--0.57
Loss (Gain) From Sale of Investments
-7.158.03-2.08-7.36-29.29
Loss (Gain) on Equity Investments
0.590.4---
Stock-Based Compensation
8.076.796.493.111.11
Provision & Write-off of Bad Debts
-0.21-0.630.410.93-
Other Operating Activities
17.16-24.23-6.25-14.55-13.6
Change in Accounts Receivable
12.98-16.48-44.227.73-74.94
Change in Inventory
1.8-35.5721.12-62.03-37.29
Change in Accounts Payable
-14.922620.1855.6723.22
Change in Unearned Revenue
7.06-11.17-22.1327.9529.7
Operating Cash Flow
348.11225.54178.15180.4672.76
Operating Cash Flow Growth
54.34%26.61%-1.28%148.03%-23.98%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-64.48-125.74-168.84-243.21-277.83
Sale of Property, Plant & Equipment
1.533.720.780.871
Cash Acquisitions
-300.18----
Sale (Purchase) of Intangibles
-50.13-40-62.36-45-25.28
Investment in Securities
-148.87-34.42-64.28-35.3819.5
Other Investing Activities
12.19.1310.896.5214.53
Investing Cash Flow
-550.03-187.31-283.81-316.18-268.08

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
738.79228.0288.3432.66-
Total Debt Issued
738.79228.0288.3432.66-
Short-Term Debt Repaid
-447.25-80-42--
Long-Term Debt Repaid
-7.04---0.19-0.32
Total Debt Repaid
-454.29-80-42-0.19-0.32
Net Debt Issued (Repaid)
284.51148.0246.3432.47-0.32
Issuance of Common Stock
-603624-
Repurchase of Common Stock
-3.61-18.92-21.26--
Common Dividends Paid
--47.12-40.32-43.68-47.31
Other Financing Activities
36.4-85.02-12.7-3.0716.56
Financing Cash Flow
317.356.978.069.72-31.07

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-6.623.083.013.72-3.19
Net Cash Flow
108.7598.29-94.6-122.28-229.58

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
283.6399.89.31-62.75-205.07
Free Cash Flow Growth
184.18%972.35%---
Free Cash Flow Margin
26.62%11.71%1.24%-10.71%-44.13%
Free Cash Flow Per Share
1.650.580.05-0.37-1.23
Levered Free Cash Flow
195.6-29.79-63.2-169.73-228.1
Unlevered Free Cash Flow
203.44-28.27-61.2-169.22-227.7

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
12.321.542.350.150.07
Cash Income Tax Paid
32.738.7319.5912.6615.02
Change in Working Capital
6.91-37.22-25.0629.31-59.32